{"id":4860,"date":"2019-04-25T15:32:20","date_gmt":"2019-04-25T10:02:20","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=4860"},"modified":"2022-10-13T10:57:36","modified_gmt":"2022-10-13T05:27:36","slug":"the-business-cocktail-ceclor","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-ceclor","title":{"rendered":"GSK to spend $100M; Lilly sell; Sherlock Bio raises $31M; Deerfield, UIC to foster research"},"content":{"rendered":"\n

GSK to spend USD 100 M to boost its vaccine production<\/strong><\/p>\n\n\n\n

Drug maker GlaxoSmithKline <\/strong>has announced to invest USD100 million <\/strong>in its vaccine production site in Montana-one of its nine manufacturing units in the USA. In order to cope with the supply issues GSK faced last year, the company wishes to boost its vaccine production including Shingrix. <\/strong>It is the only vaccine proven to be up to 90% effective at preventing shingles (herpes zoster<\/strong><\/a>) in clinical trials. <\/p>\n\n\n\n

Eli Lilly agrees to sell\nits legacy antibiotics, a manufacturing plant in China<\/strong><\/p>\n\n\n\n

Eli Lilly<\/strong> has announced to sell its antibiotic medicines, Ceclor<\/strong> and Vancocin<\/strong>, and a Ceclor producing manufacturing company in China. Eddingpharm<\/strong>, a China-based speciality pharmaceutical company, has agreed to pay Lilly USD 75 million upfront and another USD 300 million<\/strong> once the deal closes, later in this year. <\/p>\n\n\n\n

Sherlock Bio raises\nUSD 31 M in an additional A series<\/strong><\/p>\n\n\n\n

Sherlock Biosciences, <\/strong>an Engineering Biology platform dedicated to making diagnostic methods faster, better and affordable, has announced a total investment of over USD 31 million<\/strong> from Northpond<\/strong> Ventures<\/strong>, Baidu Ventures, the Open Philanthropy Project<\/strong>, and other investors. Massachusetts-based company will use the fund for making advancements in a method to identify specific sequences of genetic material in a sample using CRISPR<\/strong>; and INSPECTR<\/strong> (INternal Splint-Pairing Expression Cassette Translation Reaction for curing oncology, infectious diseases, etc. <\/p>\n\n\n\n

Deerfield, UIC to\nfoster translational research<\/strong><\/p>\n\n\n\n

Deerfield Management<\/strong> and the University of Illinois at Chicago <\/strong>together are setting up a company West Loop Innovation <\/strong>with an investment of USD 65 million.<\/strong> The new partnership will help to add funds needed for research purposes and garner critical support for the startup companies that will help commercialize UIC\u2019s research. The funding will further help UIC to advance its expertise in identifying new therapeutic targets. <\/p>\n","protected":false},"excerpt":{"rendered":"

GSK to spend USD 100 M to boost its vaccine production Drug maker GlaxoSmithKline has announced to invest USD100 million in its vaccine production site in Montana-one of its nine manufacturing units in the USA. In order to cope with the supply issues GSK faced last year, the company wishes to boost its vaccine production […]<\/p>\n","protected":false},"author":1,"featured_media":4861,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[32],"tags":[647,2150,2820,903,3506,3501],"industry":[17225],"therapeutic_areas":[17227,17231],"class_list":["post-4860","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizia","tag-crispr","tag-deerfield","tag-deerfield-management","tag-gsk","tag-shingles","tag-shingrix","industry-pharmaceutical","therapeutic_areas-immunological-and-autoimmune-disorders","therapeutic_areas-infectious-diseases"],"acf":[],"yoast_head":"\nGSK to spend $100M; Lilly sell antibiotics; Sherlock Bio raises $31M<\/title>\n<meta name=\"description\" content=\"Eli Lilly has announced to sell its antibiotic medicines, Ceclor and Vancocin, and a Ceclor producing manufacturing company in China to Eddingpharm...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-ceclor\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GSK to spend $100M; Lilly sell antibiotics; Sherlock Bio raises $31M\" \/>\n<meta property=\"og:description\" content=\"Eli Lilly has announced to sell its antibiotic medicines, Ceclor and Vancocin, and a Ceclor producing manufacturing company in China to Eddingpharm...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-ceclor\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-04-25T10:02:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-13T05:27:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/04\/04164415\/business-cocktail-25-april.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"647\" \/>\n\t<meta property=\"og:image:height\" content=\"345\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"GSK to spend $100M; Lilly sell antibiotics; Sherlock Bio raises $31M","description":"Eli Lilly has announced to sell its antibiotic medicines, Ceclor and Vancocin, and a Ceclor producing manufacturing company in China to Eddingpharm...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-ceclor","og_locale":"en_US","og_type":"article","og_title":"GSK to spend $100M; Lilly sell antibiotics; Sherlock Bio raises $31M","og_description":"Eli Lilly has announced to sell its antibiotic medicines, Ceclor and Vancocin, and a Ceclor producing manufacturing company in China to Eddingpharm...","og_url":"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-ceclor","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2019-04-25T10:02:20+00:00","article_modified_time":"2022-10-13T05:27:36+00:00","og_image":[{"width":647,"height":345,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/04\/04164415\/business-cocktail-25-april.jpg","type":"image\/jpeg"}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-ceclor","url":"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-ceclor","name":"GSK to spend $100M; Lilly sell antibiotics; Sherlock Bio raises $31M","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-ceclor#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-ceclor#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/04\/04164415\/business-cocktail-25-april.jpg","datePublished":"2019-04-25T10:02:20+00:00","dateModified":"2022-10-13T05:27:36+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"Eli Lilly has announced to sell its antibiotic medicines, Ceclor and Vancocin, and a Ceclor producing manufacturing company in China to Eddingpharm...","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-ceclor"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/the-business-cocktail-ceclor#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/04\/04164415\/business-cocktail-25-april.jpg","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/04\/04164415\/business-cocktail-25-april.jpg","width":647,"height":345,"caption":"Business cocktail 25 april"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/04\/04164415\/business-cocktail-25-april-300x160.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Notizia - Recent Pharma, Healthcare and Biotech Happenings<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Notizia - Recent Pharma, Healthcare and Biotech Happenings<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">CRISPR<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Deerfield<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Deerfield Management<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">GSK<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">shingles<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Shingrix<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">CRISPR<\/span>","<span class=\"advgb-post-tax-term\">Deerfield<\/span>","<span class=\"advgb-post-tax-term\">Deerfield Management<\/span>","<span class=\"advgb-post-tax-term\">GSK<\/span>","<span class=\"advgb-post-tax-term\">shingles<\/span>","<span class=\"advgb-post-tax-term\">Shingrix<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 7 years ago","modified":"Updated 3 years ago"},"absolute_dates":{"created":"Posted on Apr 25, 2019","modified":"Updated on Oct 13, 2022"},"absolute_dates_time":{"created":"Posted on Apr 25, 2019 3:32 pm","modified":"Updated on Oct 13, 2022 10:57 am"},"featured_img_caption":"Business cocktail 25 april","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/4860","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=4860"}],"version-history":[{"count":0,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/4860\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/4861"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=4860"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=4860"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=4860"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=4860"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=4860"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}